Literature DB >> 21856732

Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration.

Ting Yu1, Vikram G Shakkottai, Chan Chung, Andrew P Lieberman.   

Abstract

Niemann-Pick type C (NPC) disease is an autosomal recessive lysosomal storage disorder caused by mutations in the NPC1 or NPC2 genes. Loss of function mutations in either gene disrupt intracellular lipid trafficking and lead to a clinically heterogeneous phenotype that invariably includes neurological dysfunction and early death. The mechanism by which impaired lipid transport leads to neurodegeneration is poorly understood. Here we used mice with a conditional null allele to establish the timing and cell type that underlie neurodegeneration due to Npc1 deficiency. We show that global deletion of Npc1 in adult mice leads to progressive weight loss, impaired motor function and early death in a time course similar to that resulting from germline deletion. These phenotypes are associated with the occurrence of characteristic neuropathology including patterned Purkinje cell loss, axonal spheroids and reactive gliosis, demonstrating that there is not a significant developmental component to NPC neurodegeneration. Furthermore, we show that these same changes occur when Npc1 is specifically deleted only in neurons, establishing that neuronal deficiency is sufficient to mediate central nervous system (CNS) disease. In contrast, astrocyte-specific deletion does not impact behavioral phenotypes, CNS histopathology or synaptic function. We conclude that defects arising in neurons, but not in astrocytes, are the determining factor in the development of NPC neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856732      PMCID: PMC3196892          DOI: 10.1093/hmg/ddr372

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS.

Authors:  Kristen B Casper; Ken D McCarthy
Journal:  Mol Cell Neurosci       Date:  2006-02-03       Impact factor: 4.314

Review 2.  Astrocyte-neuron metabolic relationships: for better and for worse.

Authors:  Igor Allaman; Mireille Bélanger; Pierre J Magistretti
Journal:  Trends Neurosci       Date:  2011-01-13       Impact factor: 13.837

Review 3.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

4.  Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis.

Authors:  Karen S Christopherson; Erik M Ullian; Caleb C A Stokes; Christine E Mullowney; Johannes W Hell; Azin Agah; Jack Lawler; Deane F Mosher; Paul Bornstein; Ben A Barres
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

5.  Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.

Authors:  Benny Liu; Stephen D Turley; Dennis K Burns; Anna M Miller; Joyce J Repa; John M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

6.  Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration.

Authors:  Matthew J Elrick; Chris D Pacheco; Ting Yu; Nahid Dadgar; Vikram G Shakkottai; Christopher Ware; Henry L Paulson; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2009-12-10       Impact factor: 6.150

7.  Modulation of glutamatergic transmission by bergmann glial cells in rat cerebellum in situ.

Authors:  Angélique Bordey; Harald Sontheimer
Journal:  J Neurophysiol       Date:  2003-02       Impact factor: 2.714

8.  Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells.

Authors:  Lina Abi-Mosleh; Rodney E Infante; Arun Radhakrishnan; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

9.  Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1-/- mice.

Authors:  Min Zhang; Diana Strnatka; Carolyn Donohue; Janice L Hallows; Inez Vincent; Robert P Erickson
Journal:  J Neurosci Res       Date:  2008-10       Impact factor: 4.164

10.  Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.

Authors:  Cristin D Davidson; Nafeeza F Ali; Matthew C Micsenyi; Gloria Stephney; Sophie Renault; Kostantin Dobrenis; Daniel S Ory; Marie T Vanier; Steven U Walkley
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more
  32 in total

1.  Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.

Authors:  Kyle B Peake; Jean E Vance
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

2.  Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.

Authors:  Randy J Chandler; Ian M Williams; Alana L Gibson; Cristin D Davidson; Arturo A Incao; Brandon T Hubbard; Forbes D Porter; William J Pavan; Charles P Venditti
Journal:  Hum Mol Genet       Date:  2017-01-01       Impact factor: 6.150

3.  Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder.

Authors:  Chiara Di Malta; John D Fryer; Carmine Settembre; Andrea Ballabio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

4.  Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts.

Authors:  Ting Yu; Chan Chung; Dongbiao Shen; Haoxing Xu; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2012-04-14       Impact factor: 6.150

Review 5.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

6.  Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.

Authors:  Niamh X Cawley; Caitlin Sojka; Antony Cougnoux; Anna T Lyons; Elena-Raluca Nicoli; Christopher A Wassif; Forbes D Porter
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

Review 7.  Complex lipid trafficking in Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  J Inherit Metab Dis       Date:  2014-11-26       Impact factor: 4.982

Review 8.  Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease.

Authors:  Mark L Schultz; Kelsey L Krus; Andrew P Lieberman
Journal:  Brain Res       Date:  2016-03-26       Impact factor: 3.252

9.  Neuron-specific Kv1.1 deficiency is sufficient to cause epilepsy, premature death, and cardiorespiratory dysregulation.

Authors:  Krystle Trosclair; Hemangini A Dhaibar; Nicole M Gautier; Vikas Mishra; Edward Glasscock
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

10.  Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration.

Authors:  C J Ferguson; G M Lenk; J M Jones; A E Grant; J J Winters; J J Dowling; R J Giger; Miriam H Meisler
Journal:  Hum Mol Genet       Date:  2012-05-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.